Skip to main content
. 2018 Aug 4;16:59. doi: 10.1186/s12951-018-0386-6

Fig. 7.

Fig. 7

Induction of protective immunity against JEV infection with α-DC-ZZ-BNC-D3. Mice were received subcutaneous injection of α-DC-ZZ-BNC-D3 at week 0, 2, and 4. a Titers of JEV-specific total IgG in sera were determined by using ELISA (N = 6, mean ± SEM). b The mice immunized with α-DC-ZZ-BNC-D3 were challenged intraperitoneally with 50-times dose of 50% lethal dose of the JEV JaGAr01 strain followed by intracerebral inoculation with PBS